Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlation.
Keller BA, Laight BJ, Varette O, Broom A, Wedge MÈ, McSweeney B, Cemeus C, Petryk J, Lo B, Burns B, Nessim C, Ong M, Chica RA, Atkins HL, Diallo JS, Ilkow CS, Bell JC.
Keller BA, et al. Among authors: nessim c.
J Cancer Res Clin Oncol. 2021 May;147(5):1365-1378. doi: 10.1007/s00432-021-03545-2. Epub 2021 Feb 8.
J Cancer Res Clin Oncol. 2021.
PMID: 33555379